Aberdeen Group’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.21M | Buy |
3,028,872
+840,518
| +38% | +$2.28M | 0.01% | 642 |
|
|
2025
Q1 | $4.92M | Buy |
+2,188,354
| New | +$4.92M | 0.01% | 681 |
|
|
2024
Q3 | – | Sell |
-73,168
| Closed | -$263K | – | 947 |
|
|
2024
Q2 | $263K | Sell |
73,168
-744,141
| -91% | -$2.68M | ﹤0.01% | 907 |
|
|
2024
Q1 | $2.7M | Sell |
817,309
-733,773
| -47% | -$2.42M | 0.01% | 746 |
|
|
2023
Q4 | $3.58M | Buy |
+1,551,082
| New | +$3.58M | 0.01% | 724 |
|